Journal of Lipids
Volume 2012 (2012), Article ID 365798, 12 pages
http://dx.doi.org/10.1155/2012/365798
Review Article
Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?
1CNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal
2Department of Life Sciences, University of Coimbra, 3004-517 Coimbra, Portugal
3Department of Internal Medicine and Public Medicine, Clinica Medica “A. Murri”, University of Bari Medical School, 70124 Bari, Italy
Received 15 August 2011; Accepted 17 October 2011
Academic Editor: B. A. Neuschwander-Tetri
Copyright © 2012 Paulo J. Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- A. M. Gordon, S. Hurwitz, C. L. Shapiro, and M. S. Leboff, “Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer,” Menopause, vol. 18, no. 11, pp. 1244–1248, 2011. View at Google Scholar
- M. Shozu, K. Murakami, and M. Inoue, “Aromatase and leiomyoma of the uterus,” Seminars in Reproductive Medicine, vol. 22, no. 1, pp. 51–60, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. E. Schindler, “Dienogest in long-term treatment of endometriosis,” International Journal of Women's Health, vol. 3, pp. 175–184, 2011. View at Google Scholar
- D. Kaleta, B. Usidame, and K. Polańska, “Tobacco advertisements targeted on women: creating an awareness among women,” Central European Journal of Public Health, vol. 19, no. 2, pp. 73–78, 2011. View at Google Scholar
- J. C. Stevenson, “A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement,” Maturitas, vol. 70, no. 2, pp. 197–205, 2011. View at Publisher · View at Google Scholar · View at PubMed
- F. Kronenberg, “Menopausal hot flashes: a review of physiology and biosociocultural perspective on methods of assessment,” Journal of Nutrition, vol. 140, no. 7, pp. 1380S–1385S, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- R. Green and N. Santoro, “Menopausal symptoms and ethnicity: the study of Women's Health Across the Nation,” Women's Health, vol. 5, no. 2, pp. 127–133, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- H. D. Nelson, “Menopause,” The Lancet, vol. 371, no. 9614, pp. 760–770, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. L. Dormire, “The potential role of glucose transport changes in hot flash physiology: a hypothesis,” Biological Research for Nursing, vol. 10, no. 3, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. Panjari and S. R. Davis, “Vaginal DHEA to treat menopause related atrophy: a review of the evidence,” Maturitas, vol. 70, no. 1, pp. 22–25, 2011. View at Publisher · View at Google Scholar · View at PubMed
- B. Frenkel, A. Hong, S. K. Baniwal et al., “Regulation of adult bone turnover by sex steroids,” Journal of Cellular Physiology, vol. 224, no. 2, pp. 305–310, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- P. Babaei, R. Mehdizadeh, M. M. Ansar, and A. Damirchi, “Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats,” Menopause International, vol. 16, no. 3, pp. 100–104, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. L. Palin, P. G. McTernan, L. A. Anderson, D. W. Sturdee, A. H. Barnett, and S. Kumar, “17β-Estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes,” Metabolism, vol. 52, no. 4, pp. 383–388, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- H. Szafran and W. Smielak-Korombel, “The role of estrogens in hormonal regulation of lipid metabolism in women,” Przeglaąd lekarski, vol. 55, no. 5, pp. 266–270, 1998. View at Google Scholar · View at Scopus
- T. Yoshida, K. Takahashi, H. Yamatani, K. Takata, and H. Kurachi, “Impact of surgical menopause on lipid and bone metabolism,” Climacteric, vol. 14, no. 4, pp. 445–452, 2011. View at Publisher · View at Google Scholar · View at PubMed
- C. Vassalle, A. Mercuri, and S. Maffei, “Oxidative status and cardiovascular risk in women: keeping pink at heart,” World Journal of Cardiology, vol. 1, no. 1, pp. 26–30, 2009. View at Google Scholar
- I. M. Fearon and S. P. Faux, “Oxidative stress and cardiovascular disease: novel tools give (free) radical insight,” Journal of Molecular and Cellular Cardiology, vol. 47, no. 3, pp. 748–381, 2009. View at Google Scholar
- K. Tolfrey, “American Heart Association guidelines for preventing heart disease in women: 2007 Update,” Physician and Sportsmedicine, vol. 38, no. 1, pp. 162–164, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- “Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002.
- L. Mosca, S. M. Grundy, D. Judelson et al., “AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology,” Journal of American College of Cardiology, vol. 33, no. 6, pp. 1751–1755, 1999. View at Google Scholar
- L. Mosca, S. M. Grundy, D. Judelson et al., “Guide to preventive cardiology for women. AHA/ACC scientific statement consensus panel statement,” Circulation, vol. 99, no. 18, pp. 2480–2484, 1999. View at Google Scholar
- L. Mosca, H. Mochari-Greenberger, R. J. Dolor, L. K. Newby, and K. J. Robb, “Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health,” Circulation: Cardiovascular Quality and Outcomes, vol. 3, no. 2, pp. 120–127, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- H. Tunstall-Pedoe, “Myth and paradox of coronary risk and the menopause,” Lancet, vol. 351, no. 9113, pp. 1425–1427, 1998. View at Publisher · View at Google Scholar · View at Scopus
- D. J. Lerner and W. B. Kannel, “Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population,” American Heart Journal, vol. 111, no. 2, pp. 383–390, 1986. View at Google Scholar · View at Scopus
- G. M. Rosano, C. Vitale, G. Marazzi, and M. Volterrani, “Menopause and cardiovascular disease: the evidence,” Climacteric, vol. 10, no. 1, pp. 19–24, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. F. Reckelhoff and C. Maric, “Editorial: sex and gender differences in cardiovascular-renal physiology and pathophysiology,” Steroids, vol. 75, no. 11, pp. 745–746, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- V. Bittner, “Menopause, age, and cardiovascular risk: a complex relationship,” Journal of the American College of Cardiology, vol. 54, no. 25, pp. 2374–2375, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- E. S. Kim and V. Menon, “Status of women in cardiovascular clinical trials,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 3, pp. 279–283, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. Coylewright, J. F. Reckelhoff, and P. Ouyang, “Menopause and hypertension: an age-old debate,” Hypertension, vol. 51, no. 4, pp. 952–959, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. M. Grundy, “Guidelines for cholesterol management: recommendations of the National Cholesterol Education Program's Adult Treatment Panel II,” Heart Disease and Stroke, vol. 3, no. 3, pp. 123–127, 1994. View at Google Scholar · View at Scopus
- J. S. Hong, S. W. Yi, H. C. Kang et al., “Age at menopause and cause-specific mortality in South Korean women: kangwha Cohort Study,” Maturitas, vol. 56, no. 4, pp. 411–419, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- F. B. Hu, F. Grodstein, C. H. Hennekens et al., “Age at natural menopause and risk of cardiovascular disease,” Archives of Internal Medicine, vol. 159, no. 10, pp. 1061–1066, 1999. View at Publisher · View at Google Scholar · View at Scopus
- B. L. Haddock, H. P. Hopp Marshak, J. J. Mason, and G. Blix, “The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women,” Sports Medicine, vol. 29, no. 1, pp. 39–49, 2000. View at Google Scholar · View at Scopus
- K. A. Matthews, S. L. Crawford, C. U. Chae et al., “Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?” Journal of the American College of Cardiology, vol. 54, no. 25, pp. 2366–2373, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- E. Barrett-Connor, “Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture,” Circulation, vol. 95, no. 1, pp. 252–264, 1997. View at Google Scholar · View at Scopus
- H. S. Kok, K. M. van Asselt, Y. T. van der Schouw et al., “Heart disease risk determines menopausal age rather than the reverse,” Journal of the American College of Cardiology, vol. 47, no. 10, pp. 1976–1983, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- L. Mosca, C. L. Banka, E. J. Benjamin et al., “Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update,” Journal of the American College of Cardiology, vol. 49, no. 11, pp. 1230–1250, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- C. Vassalle, L. Petrozzi, N. Botto, M. G. Andreassi, and G. C. Zucchelli, “Oxidative stress and its association with coronary artery disease and different atherogenic risk factors,” Journal of Internal Medicine, vol. 256, no. 4, pp. 308–315, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- E. Schwedhelm, A. Bartling, H. Lenzen et al., “Urinary 8-iso-prostaglandin F2 α as a risk marker in patients with coronary heart disease: a matched case-control study,” Circulation, vol. 109, no. 7, pp. 843–848, 2004. View at Google Scholar
- L. Baker, K. K. Meldrum, M. Wang et al., “The role of estrogen in cardiovascular disease,” Journal of Surgical Research, vol. 115, no. 2, pp. 325–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
- O. C. Gebara, M. A. Mittleman, P. Sutherland et al., “Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study,” Circulation, vol. 91, no. 7, pp. 1952–1958, 1995. View at Google Scholar · View at Scopus
- G. A. Colditz, W. C. Willett, M. J. Stampfer et al., “Menopause and the risk of coronary heart disease in women,” New England Journal of Medicine, vol. 316, no. 18, pp. 1105–1110, 1987. View at Google Scholar
- W. J. Mack, C. C. Slater, M. Xiang, D. Shoupe, R. A. Lobo, and H. N. Hodis, “Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause,” Fertility and Sterility, vol. 82, no. 2, pp. 391–397, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. M. Shearman, L. A. Cupples, S. Demissie et al., “Association between estrogen receptor α gene variation and cardiovascular disease,” Journal of the American Medical Association, vol. 290, no. 17, pp. 2263–2270, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- F. Grodstein, M. J. Stampfer, J. E. Manson et al., “Postmenopausal estrogen and progestin use and the risk of cardiovascular disease,” New England Journal of Medicine, vol. 335, no. 7, pp. 453–461, 1996. View at Publisher · View at Google Scholar · View at Scopus
- D. Grady, S. M. Rubin, D. B. Petitti et al., “Hormone therapy to prevent disease and prolong life in postmenopausal women,” Annals of Internal Medicine, vol. 117, no. 12, pp. 1016–1037, 1992. View at Google Scholar · View at Scopus
- T. W. Meade and A. Berra, “Hormone replacement therapy and cardiovascular disease,” British Medical Bulletin, vol. 48, no. 2, pp. 276–308, 1992. View at Google Scholar · View at Scopus
- K. M. Randell, R. J. Honkanen, H. Kröger, and S. Saarikoski, “Does hormone-replacement therapy prevent fractures in early postmenopausal women?” Journal of Bone and Mineral Research, vol. 17, no. 3, pp. 528–533, 2002. View at Google Scholar · View at Scopus
- B. Ettinger, D. M. Black, B. H. Mitlak et al., “Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) investigators,” Journal of the American Medical Association, vol. 282, no. 7, pp. 637–645, 1999. View at Google Scholar
- B. E. Henderson, A. Paganini-Hill, and R. K. Ross, “Decreased mortality in users of estrogen replacement therapy,” Archives of Internal Medicine, vol. 151, no. 1, pp. 75–78, 1991. View at Publisher · View at Google Scholar · View at Scopus
- T. L. Bush, E. Barrett-Connor, L. D. Cowan et al., “Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study,” Circulation, vol. 75, no. 6, pp. 1102–1109, 1987. View at Google Scholar
- T. L. Bush, L. D. Cowan, E. Barrett Connor et al., “Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-up study,” Journal of the American Medical Association, vol. 249, no. 7, pp. 903–906, 1983. View at Publisher · View at Google Scholar
- C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, and R. Hoover, “Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk,” Journal of the American Medical Association, vol. 283, no. 4, pp. 485–491, 2000. View at Google Scholar · View at Scopus
- L. Bergkvist, H. O. Adami, I. Persson, R. Hoover, and C. Schairer, “The risk of breast cancer after estrogen and estrogen-progestin replacement,” New England Journal of Medicine, vol. 321, no. 5, pp. 293–297, 1989. View at Google Scholar · View at Scopus
- J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Google Scholar · View at Scopus
- G. L. Anderson, M. Limacher, A. R. Assaf et al., “Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial,” Journal of the American Medical Association, vol. 291, no. 14, pp. 1701–1712, 2004. View at Publisher · View at Google Scholar · View at PubMed
- A. L. Hersh, M. L. Stefanick, and R. S. Stafford, “National use of postmenopausal hormone therapy: annual trends and response to recent evidence,” Journal of the American Medical Association, vol. 291, no. 1, pp. 47–53, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. E. Rossouw, R. L. Prentice, J. E. Manson et al., “Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause,” Journal of the American Medical Association, vol. 297, no. 13, pp. 1465–1477, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. M. Harman, E. Vittinghoff, E. A. Brinton et al., “Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes,” American Journal of Medicine, vol. 124, no. 3, pp. 199–205, 2011. View at Publisher · View at Google Scholar · View at PubMed
- L. Mosca, E. J. Benjamin, K. Berra et al., “Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a Guideline from the American Heart Association,” Circulation, vol. 123, no. 11, pp. 1243–1262, 2011. View at Publisher · View at Google Scholar · View at PubMed
- M. Pierdominici, E. Ortona, F. Franconi, M. Caprio, E. Straface, and W. Malorni, “Gender specific aspects of cell death in the cardiovascular system,” Current Pharmaceutical Design, vol. 17, no. 11, pp. 1046–1055, 2011. View at Google Scholar
- A. M. Deschamps, E. Murphy, and J. Sun, “Estrogen receptor activation and cardioprotection in ischemia reperfusion injury,” Trends in Cardiovascular Medicine, vol. 20, no. 3, pp. 73–78, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. S. Juggi, L. J. Hoteit, F. A. Babiker, S. Joseph, and A. S. Mustafa, “Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-α-induced damage,” Experimental and Clinical Cardiology, vol. 16, no. 2, pp. e5–e10, 2011. View at Google Scholar
- S. Kanki, V. F. Segers, W. Wu et al., “Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium,” Circulation, vol. 4, no. 4, pp. 509–518, 2011. View at Publisher · View at Google Scholar · View at PubMed
- C. Huang, H. Gu, Y. Wang, and M. Wang, “Estrogen-induced SDF-1 production is mediated by estrogen receptor-α in female hearts after acute ischemia and reperfusion,” Surgery, vol. 150, no. 2, pp. 197–203, 2011. View at Google Scholar
- J. Cao, T. Zhu, L. Lu et al., “Estrogen induces cardioprotection in male C57BL/6J mice after acute myocardial infarction via decreased activity of matrix metalloproteinase-9 and increased Akt-Bcl-2 anti-apoptotic signaling,” International Journal of Molecular Medicine, vol. 28, no. 2, pp. 231–237, 2011. View at Publisher · View at Google Scholar · View at PubMed
- L. F. Valverdea, F. D. Cedillob, M. L. Ramosa, E. G. Cerveraa, K. Quijanoa, and J. Cordobaa, “Changes induced by estradiol-ethylenediamine derivative on perfusion pressure and coronary resistance in isolated rat heart: l-type calcium channel,” Biomedical Papers, vol. 155, no. 1, pp. 27–32, 2011. View at Publisher · View at Google Scholar
- X. Hu, X. Xu, Z. Lu et al., “AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development,” Hypertension, vol. 58, no. 4, pp. 696–703, 2011. View at Publisher · View at Google Scholar · View at PubMed
- M. S. Mitra, J. D. Schilling, X. Wang et al., “Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 1, pp. 120–128, 2011. View at Publisher · View at Google Scholar · View at PubMed
- D. E. Masood, E. C. Roach, K. G. Beauregard, and R. A. Khalil, “Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease,” Current Drug Metabolism, vol. 11, no. 8, pp. 693–714, 2010. View at Publisher · View at Google Scholar
- P. A. Arias-Loza, K. Hu, S. Frantz et al., “Medroxyprogesterone acetate aggravates oxidative stress and left ventricular dysfunction in rats with chronic myocardial infarction,” Toxicologic Pathology, vol. 39, no. 5, pp. 867–878, 2011. View at Publisher · View at Google Scholar · View at PubMed
- G. D. Lopaschuk, J. R. Ussher, C. D. Folmes, J. S. Jaswal, and W. C. Stanley, “Myocardial fatty acid metabolism in health and disease,” Physiological Reviews, vol. 90, no. 1, pp. 207–258, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- R. M. Beadle and M. Frenneaux, “Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease,” Heart, vol. 96, no. 11, pp. 824–830, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. Kerner and C. Hoppel, “Fatty acid import into mitochondria,” Biochimica et Biophysica Acta, vol. 1486, no. 1, pp. 1–17, 2000. View at Publisher · View at Google Scholar · View at Scopus
- Y. G. Niu and R. D. Evans, “Very-low-density lipoprotein: complex particles in cardiac energy metabolism,” Journal of Lipid Research, vol. 2011, Article ID 189876, 9 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
- Y. G. Niu, D. Hauton, and R. D. Evans, “Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates,” Journal of Physiology, vol. 558, no. 1, pp. 225–237, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. F. Oliver, “Control of free fatty acids during acute myocardial ischaemia,” Heart, vol. 96, no. 23, pp. 1883–1884, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. Barsotti, A. Giannoni, P. di Napoli, and M. Emdin, “Energy metabolism in the normal and in the diabetic heart,” Current Pharmaceutical Design, vol. 15, no. 8, pp. 836–840, 2009. View at Publisher · View at Google Scholar · View at Scopus
- G. J. van der Vusse, M. van Bilsen, J. F. Glatz, D. M. Hasselbaink, and J. J. Luiken, “Critical steps in cellular fatty acid uptake and utilization,” Molecular and Cellular Biochemistry, vol. 239, no. 1-2, pp. 9–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
- J. F. Glatz, J. J. Luiken, and A. Bonen, “Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake,” Journal of Molecular Neuroscience, vol. 16, no. 2-3, pp. 123–132, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. F. Glatz, J. J. Luiken, F. A. van Nieuwenhoven, and G. J. van der Vusse, “Molecular mechanism of cellular uptake and intracellular translocation of fatty acids,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 57, no. 1, pp. 3–9, 1997. View at Publisher · View at Google Scholar · View at Scopus
- A. T. Turer, C. R. Malloy, C. B. Newgard, and M. V. Podgoreanu, “Energetics and metabolism in the failing heart: important but poorly understood,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 458–465, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. E. Young, G. W. Goodwin, J. Ying et al., “Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids,” American Journal of Physiology: Endocrinology and Metabolism, vol. 280, no. 3, pp. E471–E479, 2001. View at Google Scholar
- S. Eaton, “Control of mitochondrial β-oxidation flux,” Progress in Lipid Research, vol. 41, no. 3, pp. 197–239, 2002. View at Publisher · View at Google Scholar · View at Scopus
- S. Grimbert, C. Fisch, D. Deschamps et al., “Effects of female sex hormones on mitochondria: possible role in acute fatty liver of pregnancy,” American Journal of Physiology, vol. 268, no. 1, pp. G107–G115, 1995. View at Google Scholar · View at Scopus
- R. Sladek, J. A. Bader, and V. Giguère, “The orphan nuclear receptor estrogen-related receptor or α is a transcriptional regulator of the human medium-cha n Acyl coenzyme A dehydrogenase gene,” Molecular and Cellular Biology, vol. 17, no. 9, pp. 5400–5409, 1997. View at Google Scholar · View at Scopus
- L. O. Li, E. L. Klett, and R. A. Coleman, “Acyl-CoA synthesis, lipid metabolism and lipotoxicity,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 246–251, 2010. View at Publisher · View at Google Scholar · View at PubMed
- N. A. van Herpen and V. B. Schrauwen-Hinderling, “Lipid accumulation in non-adipose tissue and lipotoxicity,” Physiology and Behavior, vol. 94, no. 2, pp. 231–241, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- L. S. Szczepaniak, R. G. Victor, L. Orci, and R. H. Unger, “Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America,” Circulation Research, vol. 101, no. 8, pp. 759–767, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- N. M. Borradaile and J. E. Schaffer, “Lipotoxicity in the heart,” Current Hypertension Reports, vol. 7, no. 6, pp. 412–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
- L. Zhang, J. R. Ussher, T. Oka, V. J. Cadete, C. Wagg, and G. D. Lopaschuk, “Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation,” Cardiovascular Research, vol. 89, no. 1, pp. 148–156, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- I. Chowdhury, A. Branch, M. Olatinwo, K. Thomas, R. Matthews, and W. E. Thompson, “Prohibitin (PHB) acts as a potent survival factor against ceramide induced apoptosis in rat granulosa cells,” Life Sciences, vol. 89, no. 9-10, pp. 295–303, 2011. View at Publisher · View at Google Scholar · View at PubMed
- T. D. Mullen and L. M. Obeid, “Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death,” Anti-Cancer Agents in Medicinal Chemistry. In press.
- H. Lee, J. A. Rotolo, J. Mesicek et al., “Mitochondrial ceramide-rich macrodomains functionalize bax upon irradiation,” PLoS ONE, vol. 6, no. 6, article e19783, 2011. View at Publisher · View at Google Scholar · View at PubMed
- E. Usta, M. Mustafi, F. Artunc et al., “The challenge to verify ceramide's role of apoptosis induction in human cardiomyocytes—a pilot study,” Journal of Cardiothoracic Surgery, vol. 6, no. 1, article 38, 2011. View at Publisher · View at Google Scholar · View at PubMed
- S. A. Novgorodov, Z. M. Szulc, C. Luberto et al., “Positively charged ceramide is a potent inducer of mitochondrial permeabilization,” Journal of Biological Chemistry, vol. 280, no. 16, pp. 16096–16105, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. di Paola, P. Zaccagnino, G. Montedoro, T. Cocco, and M. Lorusso, “Ceramide induces release of pro-apoptotic proteins from mitochondria by either a Ca2+-dependent or a Ca2+-independent mechanism,” Journal of Bioenergetics and Biomembranes, vol. 36, no. 2, pp. 165–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
- K. W. Kinnally, P. M. Peixoto, S.-Y. Ryu, and L. M. Dejean, “Is mPTP the gatekeeper for necrosis, apoptosis, or both?” Biochimica et Biophysica Acta, vol. 1813, no. 4, pp. 616–622, 2011. View at Publisher · View at Google Scholar · View at PubMed
- S. A. Novgorodov, T. I. Gudz, and L. M. Obeid, “Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore,” Journal of Biological Chemistry, vol. 283, no. 36, pp. 24707–24717, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. A. Cole, A. J. Murray, L. E. Cochlin et al., “A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart,” Basic Research in Cardiology, vol. 106, no. 3, pp. 447–457, 2011. View at Publisher · View at Google Scholar · View at PubMed
- N. Li, J. Wang, F. Gao, Y. Tian, R. Song, and S.-J. Zhu, “The role of uncoupling protein 2 in the apoptosis induced by free fatty acid in rat cardiomyocytes,” Journal of Cardiovascular Pharmacology, vol. 55, no. 2, pp. 161–167, 2010. View at Publisher · View at Google Scholar · View at PubMed
- L. H. Opie and J. Knuuti, “The adrenergic-fatty acid load in heart failure,” Journal of the American College of Cardiology, vol. 54, no. 18, pp. 1637–1646, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. S. Jaswal, W. Keung, W. Wang, J. R. Ussher, and G. D. Lopaschuk, “Targeting fatty acid and carbohydrate oxidation—a novel therapeutic intervention in the ischemic and failing heart,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1333–1350, 2011. View at Publisher · View at Google Scholar · View at PubMed
- M. J. Romero-Aleshire, M. K. Diamond-Stanic, A. H. Hasty, P. B. Hoyer, and H. L. Brooks, “Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 297, no. 3, pp. R587–R592, 2009. View at Publisher · View at Google Scholar · View at PubMed
- F. Pansini, G. Bonaccorsi, F. Genovesi et al., “Influence of estrogens on serum free fatty acid levels in women,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 5, pp. 1387–1389, 1990. View at Google Scholar
- C. A. Derby, S. L. Crawford, R. C. Pasternak et al., “Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation,” American Journal of Epidemiology, vol. 169, no. 11, pp. 1352–1361, 2009. View at Google Scholar
- M. L. Power and J. Schulkin, “Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins,” British Journal of Nutrition, vol. 99, no. 5, pp. 931–940, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- T. M. D'Eon, S. C. Souza, M. Aronovitz, M. S. Obin, S. K. Fried, and A. S. Greenberg, “Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways,” Journal of Biological Chemistry, vol. 280, no. 43, pp. 35983–35991, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- C. M. Williams, “Lipid metabolism in women,” Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 153–160, 2004. View at Google Scholar
- A. K. Wong, J. Howie, J. R. Petrie, and C. C. Lang, “AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease,” Clinical Science, vol. 116, no. 8, pp. 607–620, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- C.-M. Liou, A.-L. Yang, C.-H. Kuo, H. Tin, C.-Y. Huang, and S.-D. Lee, “Effects of 17β-estradiol on cardiac apoptosis in ovariectomized rats,” Cell Biochemistry and Function, vol. 28, no. 6, pp. 521–528, 2010. View at Publisher · View at Google Scholar · View at PubMed
- S. D. Lee, W. W. Kuo, Y. J. Ho et al., “Cardiac Fas-dependent and mitochondria-dependent apoptosis in ovariectomized rats,” Maturitas, vol. 61, no. 3, pp. 268–277, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- W.-C. Liang and I. Nishino, “State of the art in muscle lipid diseases,” Acta Myologica, vol. 29, no. 2, pp. 351–356, 2010. View at Google Scholar
- M. J. Bennett, “Pathophysiology of fatty acid oxidation disorders,” Journal of Inherited Metabolic Disease, vol. 33, no. 5, pp. 533–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. Begriche, J. Massart, M.-A. Robin, A. Borgne-Sanchez, and B. Fromenty, “Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver,” Journal of Hepatology, vol. 54, no. 4, pp. 773–794, 2011. View at Publisher · View at Google Scholar · View at PubMed
- J. A. Bjork, J. L. Butenhoff, and K. B. Wallace, “Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes,” Toxicology, vol. 288, no. 1–3, pp. 8–17, 2011. View at Publisher · View at Google Scholar · View at PubMed
- E. Freneaux, G. Labbe, P. Letteron et al., “Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic,” Hepatology, vol. 8, no. 5, pp. 1056–1062, 1988. View at Google Scholar · View at Scopus
- D. J. Glenn, F. Wang, M. Nishimoto et al., “A murine model of isolated cardiac steatosis leads to cardiomyopathy,” Hypertension, vol. 57, no. 2, pp. 216–222, 2011. View at Publisher · View at Google Scholar · View at PubMed
- G. Petrosillo, M. Matera, N. Moro, F. M. Ruggiero, and G. Paradies, “Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin,” Free Radical Biology and Medicine, vol. 46, no. 1, pp. 88–94, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- E. J. Lesnefsky and C. L. Hoppel, “Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat,” Biochimica et Biophysica Acta, vol. 1777, no. 7-8, pp. 1020–1027, 2008. View at Publisher · View at Google Scholar · View at PubMed
- H. J. Lee, J. Mayette, S. I. Rapoport, and R. P. Bazinet, “Selective remodeling of cardiolipin fatty acids in the aged rat heart,” Lipids in Health and Disease, vol. 5, article 2, 2006. View at Publisher · View at Google Scholar · View at PubMed
- S. Judge, Y. M. Jang, A. Smith, T. Hagen, and C. Leeuwenburgh, “Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging,” FASEB Journal, vol. 19, no. 3, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. W. Fannin, E. J. Lesnefsky, T. J. Slabe, M. O. Hassan, and C. L. Hoppel, “Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria,” Archives of Biochemistry and Biophysics, vol. 372, no. 2, pp. 399–407, 1999. View at Publisher · View at Google Scholar · View at PubMed
- C. C. Preston, A. S. Oberlin, E. L. Holmuhamedov et al., “Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart,” Mechanisms of Ageing and Development, vol. 129, no. 6, pp. 304–312, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. Marín-García, Y. Pi, and M. J. Goldenthal, “Mitochondrial-nuclear cross-talk in the aging and failing heart,” Cardiovascular Drugs and Therapy, vol. 20, no. 6, pp. 477–491, 2006. View at Publisher · View at Google Scholar · View at PubMed
- S. A. Mohamed, T. Hanke, A. W. Erasmi et al., “Mitochondrial DNA deletions and the aging heart,” Experimental Gerontology, vol. 41, no. 5, pp. 508–517, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. R. Meyer, D. J. Clegg, E. R. Prossnitz, and M. Barton, “Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors,” Acta Physiologica, vol. 203, no. 1, pp. 259–269, 2011. View at Publisher · View at Google Scholar · View at PubMed
- B. Niemann, Y. Chen, M. Teschner, L. Li, R.-E. Silber, and S. Rohrbach, “Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria,” Journal of the American College of Cardiology, vol. 57, no. 5, pp. 577–585, 2011. View at Publisher · View at Google Scholar · View at PubMed
- J. G. Duncan, “Mitochondrial dysfunction in diabetic cardiomyopathy,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1351–1359, 2011. View at Publisher · View at Google Scholar · View at PubMed
- P. J. Oliveira, “Cardiac mitochondrial alterations observed in hyperglycaemic rats—what can we learn from cell biology?” Current Diabetes Reviews, vol. 1, no. 1, pp. 11–21, 2005. View at Publisher · View at Google Scholar · View at Scopus
- J. Suski, M. Lebiedzinska, N. G. Machado et al., “Mitochondrial tolerance to drugs and toxic agents in ageing and disease,” Current Drug Targets, vol. 12, no. 6, pp. 827–849, 2011. View at Publisher · View at Google Scholar
- V. A. Sardão, S. L. Pereira, and P. J. Oliveira, “Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury,” Expert Opinion on Drug Safety, vol. 7, no. 2, pp. 129–146, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. Ascensão, J. Lumini-Oliveira, P. J. Oliveira, and J. Magalhães, “Mitochondria as a target for exercise-induced cardioprotection,” Current Drug Targets, vol. 12, no. 6, pp. 860–871, 2011. View at Publisher · View at Google Scholar
- J. Lumini-Oliveira, J. Magalhães, C. V. Pereira, A. C. Moreira, P. J. Oliveira, and A. Ascensão, “Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia,” Mitochondrion, vol. 11, no. 1, pp. 54–63, 2011. View at Publisher · View at Google Scholar · View at PubMed
- M. L. Johnson, Z. Zarins, J. A. Fattor et al., “Twelve weeks of endurance training increases FFA mobilization and reesterification in postmenopausal women,” Journal of Applied Physiology, vol. 109, no. 6, pp. 1573–1581, 2010. View at Publisher · View at Google Scholar · View at PubMed
- Z. A. Zarins, G. A. Wallis, N. Faghihnia et al., “Effects of endurance training on cardiorespiratory fitness and substrate partitioning in postmenopausal women,” Metabolism, vol. 58, no. 9, pp. 1338–1346, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. M. Moustafa and V. Boshra, “The possible role of L-carnitine on the skeletal muscle of ovariectomized rats,” Journal of Molecular Histology, vol. 42, no. 3, pp. 217–225, 2011. View at Publisher · View at Google Scholar · View at PubMed
- I. Baeza, J. Fdez-Tresguerres, C. Ariznavarreta, and M. De La Fuente, “Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats,” Biogerontology, vol. 11, no. 6, pp. 687–701, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- R. E. White, R. Gerrity, S. A. Barman, and G. Han, “Estrogen and oxidative stress: a novel mechanism that may increase the risk for cardiovascular disease in women,” Steroids, vol. 75, no. 11, pp. 788–793, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J.-F. Arnal, P.-Y. Scarabin, F. Trémollières, H. Laurell, and P. Gourdy, “Estrogens in vascular biology and disease: where do we stand today?” Current Opinion in Lipidology, vol. 18, no. 5, pp. 554–560, 2007. View at Publisher · View at Google Scholar · View at PubMed
- T. L. Zern, R. J. Wood, C. Greene et al., “Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress,” Journal of Nutrition, vol. 135, no. 8, pp. 1911–1917, 2005. View at Google Scholar · View at Scopus
- M. Sun, F. Qian, W. Shen et al., “Mitochondrial nutrients stimulate performance and mitochondrial biogenesis in exhaustively exercised rats,” Scandinavian Journal of Medicine and Science in Sports. In press.
- A. Biala, E. Tauriainen, A. Siltanen et al., “Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes,” Blood Pressure, vol. 19, no. 3, pp. 196–205, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- G. Szabó, “A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 297, no. 1, pp. H8–H9, 2009. View at Publisher · View at Google Scholar · View at PubMed